Lepu Biopharma Co., Ltd. (2157.HK)
HKD 5.05
(0.2%)
HKD 5.05
(0.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 746.82 Million CNY | 8.19% |
| 2022 | 690.3 Million CNY | 105.9% |
| 2021 | 335.26 Million CNY | 65.09% |
| 2020 | 203.07 Million CNY | -64.84% |
| 2019 | 577.53 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 729.61 Million CNY | -2.3% |
| 2024 Q2 | 729.61 Million CNY | 6.21% |
| 2023 Q4 | 746.82 Million CNY | 3.94% |
| 2023 FY | 746.82 Million CNY | 8.19% |
| 2023 Q3 | 718.48 Million CNY | -7.35% |
| 2023 Q2 | 775.5 Million CNY | 3.26% |
| 2023 Q1 | 751.05 Million CNY | 8.8% |
| 2022 Q2 | 454.34 Million CNY | 5.14% |
| 2022 Q1 | 432.15 Million CNY | 28.9% |
| 2022 FY | 690.3 Million CNY | 105.9% |
| 2022 Q4 | 690.3 Million CNY | 5.69% |
| 2022 Q3 | 653.13 Million CNY | 43.75% |
| 2021 FY | 335.26 Million CNY | 65.09% |
| 2021 Q4 | 335.26 Million CNY | 39.74% |
| 2021 Q3 | 239.92 Million CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2020 FY | 203.07 Million CNY | -64.84% |
| 2019 FY | 577.53 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -1312.643% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 87.408% |